Therefore, we use meta-analysis in Oncomine platform to assess TET3 gene expression in ovarian cancer [10], followed by integration analysis using a larger sample size including 14 studies in GEO datasets [11], and further validated with gene expression from TCGA and GTEx. This evidence concerns the gene TET3 and ovarian cancer.